- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
New report gives phase IV performance stats
How often pharmaceutical companies actually perform postmarketing trials (phase IV) are contained in a report from Cutting Edge Information, an industry intelligence firm. The top 20 pharmaceutical companies initiate phase IV trials for 87% of new products, while 92% of mid-sized companies will perform the postmarketing studies. Small companies conduct the trials only 69% of the time. The report, entitled Phase IV Clinical Trials: Post-Marketing Study Management Structure, Strategy, and Benchmarks, is available on-line at www.postmarketingtrials.com. It includes clinical trial performance measures such as cycle times, resource-based measures, and efficiency or operational metricssuch as patient retention rates and data errors. Average per-patient clinical trial costs by therapeutic area are also included in the new report.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
Stress Ulcer Prophylaxis May Not Prevent Gastrointestinal Bleeding in Neonates
December 4th 2023According to a poster presented at ASHP Midyear 2023, stress ulcer prophylaxis (SUP) did not increase adverse effects, suggesting limited preventive benefits for gastrointestinal bleeding (GIB) in neonates.
Instagram Could Serve as Educational Platform for New FDA Drug Approvals
December 4th 2023An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.
